Part A and Part B were randomised , double-blind , placebo-controlled , Bayesian adaptive dose finding studies to investigate the safety , tolerability , efficacy , pharmacokinetics and pharmacodynamics of single ( Part A ) and 3 repeat ( Part B ) intravenous infusions of GSK315234 in patients with active RA on a background of methotrexate ( MTX ) .